Abstract:Objective To study the changes of angiotensin-converting enzyme 2(ACE2)/angiotensin (1-7)[Ang(1-7)]/Mas axis and transforming growth factor-beta 1(TGF-β1) in renovascular hypertensive rats and explore the cardioprotective mechanism of zofenopril on myocardial hypertrophy. Methods A total of 68 male Sprague-Dawly rats were randomly divided into sham-operation group (n=18) and 2-kidney,1-clip (2K1C) group (n=50). 2K1C hypertensive model was established. The systolic bood pressure (SBP) was measured by the tail-cuff method 4 weeks later. The hypertensive rats were randomly divided into model group (n=22) and zofenopril [10 mg/(kg·d)] group (n=22). Postoperative SBP measurements were performed 8, 12 and 14 weeks later, respectively. Cardiac structure and function were assessed by cardiac ultrasonography. SBP, cardiac ultrasonography were measured at the 8th, 12th and 14th week respectively. The plasma Ang(1-7) and TGF-β1 were evaluated by ELISA, the mRNA levels of ACE2, Mas and TGF-β1 detected by RT-PCR, and the protein levels of ACE2 and Mas receptor tested by Western blotting. Results ①The SBP,ventricular septal thickness and posterior left ventricular wall thickness increased significantly in 2K1C rats, while lower SBP and reversed ventricular hypertrophy was noted in zofenopril group (both P0.01). ②The plasma Ang(1-7) was higher in hypertensive model group than in sham operation group at the 8th and 12th week. After being given zofenopril, Ang(1-7) increased sharply at the 12th and 14th week except the 8th week. ③The serum levels of TGF-β1 were significantly higher in model group than in sham-operation group and zofenopril group at each time point[ 8th week: (22.03±1.09) vs (14.22±1.24) vs (16.29±1.41); 12th week: (23.95±1.41) vs (14.26±1.28) vs (14.39±1.38); 14th week: (25.91±1.59) vs (13.98±1.07) vs (14.48±1.52)ng/L; all P0.01]. ④In contrast to those of sham-operation group, the ACE2 and Mas expressions in model group were upregulated at the 8th week, but downregulated at the 12th and 14th week (both P0.01). After being treated with zofenopril, the myocardial levels of ACE2 and Mas decreased at the 8th week but increased at the 12th and 14th week. Conclusion Zofenopril can significantly reduce the blood pressure and attenuate cardiac hypertrophy of renovascular hypertensive rats, while enhancing the ACE2/angiotensin (1-7)/Mas receptor axis and reducing the TGF-β1 expression, which may partly contribute to its cardioprotective effect.

Effects of Zofenopril on Expressions of Angiotensin-Converting Enzyme 2/angiotensin (1-7)/Mas and Transforming Growth Factor-Beta 1 in Hypertrophied Myocardium of Renovascular Hypertensive Rats